Segment Information (Tables)

9 Months Ended

Sep. 30, 2012

Net Sales and Segment Operating Profit

Net sales and segment operating profit are as follows (in millions):

	Net Sales				Operating Profit
	Three Months Ended September 30,				Three Months Ended September 30,
	2012		2011		2012			2011
Americas	$	583.5	$	582.1	$	291.0		$	293.2
Europe		245.6		252.5		65.5			75.0
Asia Pacific		196.4		196.9		75.3			69.2
Total	$	1,025.5	$	1,031.5
Share-based compensation						(13.9	)		(14.4	)
Inventory step-up						(0.5	)		(1.8	)
Special items						(36.9	)		(8.0	)
Global operations and corporate functions						(131.1	)		(146.6	)
Operating profit					$	249.4		$	266.6

	Net Sales				Operating Profit
	Nine Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012			2011
Americas	$	1,832.2	$	1,820.4	$	927.8		$	906.6
Europe		851.6		876.4		254.7			289.6
Asia Pacific		607.4		587.7		232.0			216.2
Total	$	3,291.2	$	3,284.5
Share-based compensation						(41.7	)		(46.1	)
Inventory step-up						(2.5	)		(9.6	)
Certain claims						—			(50.0	)
Special items						(101.1	)		(47.0	)
Global operations and corporate functions						(422.3	)		(436.8	)
Operating profit					$	846.9		$	822.9

Net Sales by Product Category

Net sales by product category are as follows (in millions):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2012		2011		2012		2011
Reconstructive
Knees	$	407.4	$	416.7	$	1,338.7	$	1,349.8
Hips		308.5		315.6		993.0		997.9
Extremities		39.7		36.0		127.0		119.6
		755.6		768.3		2,458.7		2,467.3
Dental		54.7		55.1		176.4		184.6
Trauma		74.5		69.3		223.9		208.5
Spine		49.8		55.2		155.4		168.5
Surgical and other		90.9		83.6		276.8		255.6
Total	$	1,025.5	$	1,031.5	$	3,291.2	$	3,284.5